Almost £8 billion has been erased from the value of the world’s largest pharmaceutical companies following the unexpected ousting of America’s leading vaccine authority by Robert F Kennedy Jr. Shares
Healthcare7- Page
177Articles
Pfizer has completed the sale of its remaining 7% stake in Haleon, the FTSE 100 consumer healthcare company, raising £2.4 billion. This transaction, involving the placement of 618 million shares
Bupa’s only UK hospital, Cromwell Hospital in Kensington, West London, is gearing up for expansion. Currently housing 100 beds, 700 consultants, and 900 staff, the hospital has established itself as
Oxford Medical Simulation, a UK-based virtual reality (VR) training company, has shifted its primary focus to the United States, citing bureaucratic obstacles within the NHS as a major hindrance to
One of the UK’s leading care providers, Cera, is trialling the use of robots to deliver support and improve care for elderly and vulnerable individuals. Collaborating with North Northamptonshire Council,
The recent alignment of seven major planets over Britain coincided with promising developments in the field of genetics, particularly for UK-based Genomics, a genetic analytics firm spearheading a transformative approach
The takeover of Assura, one of the NHS’s largest landlords, appears to have moved a step closer after the American private equity firm KKR, in partnership with Stonepeak, raised its
A significant NHS property owner has suspended the construction of new medical facilities across the UK until governmental authorities agree to increase rental rates to economically sustainable levels. Primary Health
In a significant development for the healthcare technology sector, Apple’s AirPods Pro 2, have received approval to function as clinical-grade hearing aids in the UK market. This breakthrough comes following
The FTSE 100 medical equipment manufacturer Smith & Nephew faces intensifying shareholder pressure to consider a corporate break-up ahead of its annual results next week, particularly if its struggling orthopaedics
In an unprecedented shift within the underground pharmaceutical market, drug dealers across the UK are diversifying their offerings to include sought-after weight-loss medications alongside traditional illicit substances. The weight-loss injection
British online pharmacies have witnessed extraordinary growth, with some providers reporting up to 300% increase in demand, primarily driven by the surging popularity of weight-loss medications. Market analysis from SpendMapper
Market observers and healthcare analysts are closely monitoring a groundbreaking development in the oncology sector, where a pioneering immunotherapy treatment has demonstrated remarkable longevity in its effectiveness. A patient treated
A significant move in the UK healthcare property sector emerged today as American private equity firm KKR partnered with the Universities Superannuation Scheme (USS) to make a takeover bid for
The NHS is seeking private sector funding to address its deteriorating infrastructure and record-breaking emergency department waiting times. Amanda Pritchard, the organisation’s chief executive, has urged ministers to adopt a
Recent clinical trials have unveiled a significant breakthrough in the potential application of weight-loss medication Semaglutide, marketed as Wegovy, in reducing alcohol consumption. The groundbreaking study demonstrated a remarkable 40%
